The abstract is read at the publisher; the summary is JClub's.
Higher RAPGEF1 expression at the 9q34.13 melanoma/nevus locus is linked to increased melanocyte growth and colony formation, and activates RAP1 and RAS after EGF treatment.
- Why it matters: The study addresses how a chromosome 9q34.13 risk locus influences melanoma and nevus burden, and which regulatory variants and genes modulate RAS signaling in melanocytes and tumors.
- What they did: Using fine-mapping with melanocyte expression data, colocalization and conditional TWAS, plus melanocyte capture-HiC and CRISPR inhibition, the authors tested regulatory links to RAPGEF1 and UCK1; they then overexpressed RAPGEF1 in human immortalized melanocytes and stimulated with EGF.
- The result: RAPGEF1 overexpression promoted melanocyte growth and colony formation and, after EGF, activated both RAP1 and RAS; RAPGEF1 expression was enriched in melanomas lacking strongly activating RAS-MAPK mutations, with preliminary prognostic relevance in melanomas lacking RAS or BRAF mutations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.